D. Western Therapeutics Institute, Inc. (TYO:4576)
Japan · Delayed Price · Currency is JPY 94.00
+1.00 (1.06%)
Apr 17, 2026, 3:30 PM JST
TYO:4576 Revenue
In the year 2025, D. Western Therapeutics Institute had annual revenue of 387.00M JPY, down -17.83%. D. Western Therapeutics Institute had revenue of 89.90M in the quarter ending December 31, 2025, a decrease of -26.36%.
Revenue
387.00M
Revenue Growth
-17.83%
P/S Ratio
13.20
Revenue / Employee
20.37M
Employees
19
Market Cap
5.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 387.00M | -84.00M | -17.83% |
| Dec 31, 2024 | 471.00M | 43.00M | 10.05% |
| Dec 31, 2023 | 428.00M | -20.00M | -4.46% |
| Dec 31, 2022 | 448.00M | 34.00M | 8.21% |
| Dec 31, 2021 | 414.00M | 59.00M | 16.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Transgenic Group | 12.89B |
| Linical | 9.32B |
| Kohjin Bio | 5.07B |
| Soiken Holdings | 4.58B |
| PRISM BioLab Co.,LTD | 684.61M |
| Chiome Bioscience | 593.29M |
| Kringle Pharma | 72.62M |
| ADR120S | 40.00M |